Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion-associated viral infections.

S Baldwin1, S Stagno, R Whitley

  • 1Department of Pediatrics and Microbiology, University of Alabama, Birmingham School of Medicine.

Current Problems in Pediatrics
|July 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A process evaluation of Promotional Guides used by health visitors to support men's transition to fatherhood: a qualitative study.

Perspectives in public health·2022
Same author

Student learning styles in anatomy and physiology courses: Meeting the needs of nursing students.

Nurse education in practice·2015
Same author

The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.

Clinical pharmacology and therapeutics·2014
Same author

What's the message? A content analysis of newspaper articles about assisted reproductive technology from 2005 to 2011.

Human fertility (Cambridge, England)·2014
Same author

Social support and religion: mental health service use and treatment of schizophrenia.

Community mental health journal·2012
Same author

Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.

Clinical pharmacology and therapeutics·2007

Minimize viral infections from blood transfusions by judicious use, volunteer donors, and rigorous testing for HBsAg, HIV, and ALT levels. Employ heat-treated clotting factors and consider CMV status for high-risk patients.

Area of Science:

  • Transfusion Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Viral infections are a significant risk associated with blood product transfusions.
  • These infections can lead to substantial patient morbidity and mortality.
  • Implementing preventive strategies is crucial for patient safety.

Purpose of the Study:

  • To outline essential measures for reducing the risk of viral infections post-transfusion.
  • To provide a comprehensive guide for healthcare professionals on safe transfusion practices.
  • To emphasize the importance of screening and product selection in preventing transfusion-transmitted viral diseases.

Main Methods:

  • Review and synthesis of established guidelines for blood product safety.
  • Identification of key interventions to mitigate viral transmission risks.

Related Experiment Videos

  • Focus on donor selection, product testing, and specific product modifications.

    • Main Results:

    • Recommendations include: judicious transfusion, use of volunteer donors, avoiding pooled products.
    • Mandatory testing for Hepatitis B surface antigen (HBsAg) and Human Immunodeficiency Virus (HIV).
    • ALT screening, use of heat-treated clotting factors, limited leukocyte transfusions, and CMV-negative products for at-risk groups.

    Conclusions:

    • Adherence to these measures significantly reduces the incidence of transfusion-associated viral infections.
    • Careful patient selection and rigorous screening protocols are paramount.
    • Proactive management of blood product use enhances patient outcomes and safety.